Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Tansley

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Rheumatology (Oxford, England)|March 13, 2024
Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohortAravinthan Loganathan, Latika Gupta, Alex Rudge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Anti-Cytosolic 5'-Nucleotidase 1A Autoantibodies Are Absent in Juvenile DermatomyositisAnke Rietveld, Judith Wienke, Eline Visser, et al.
Rheumatology (Oxford, England)|March 18, 2024
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patientsHuong D Nguyen, Fabienne Jouen, Benoit Déchelotte, et al.
Biomolecules|May 27, 2026
Clinical Relevance and Methodological Comparison of Anti-MDA5 Antibody Detection: A Five-Year Retrospective and Exploratory Pilot StudySándor Mogyoróssy, Gábor Nagy, Zoltán Griger, et al.
Annals of the Rheumatic Diseases|June 20, 2025
The TFIID complex is a new autoantibody target in systemic sclerosisJean-Baptiste Vulsteke, Birthe Michiels, Vanessa Smith, et al.
Rheumatology (Oxford, England)|February 18, 2021
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathiesAlexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Rheumatology (Oxford, England)|October 24, 2021
Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathiesAlexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Ebiomedicine|September 28, 2023
Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathiesValérie Leclair, Angeles S Galindo-Feria, Simon Rothwell, et al.
Autoimmunity Reviews|March 13, 2026
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature reviewValentin Pillot, Segolene Toquet, Jean Luc Charuel, et al.
Seminars in Arthritis and Rheumatism|November 2, 2025
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysisTakahisa Gono, Albert Gil-Vila, Albert Selva-O'Callaghan, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|March 13, 2024
Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohortAravinthan Loganathan, Latika Gupta, Alex Rudge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Anti-Cytosolic 5'-Nucleotidase 1A Autoantibodies Are Absent in Juvenile DermatomyositisAnke Rietveld, Judith Wienke, Eline Visser, et al.
Rheumatology (Oxford, England)|March 18, 2024
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patientsHuong D Nguyen, Fabienne Jouen, Benoit Déchelotte, et al.
Biomolecules|May 27, 2026
Clinical Relevance and Methodological Comparison of Anti-MDA5 Antibody Detection: A Five-Year Retrospective and Exploratory Pilot StudySándor Mogyoróssy, Gábor Nagy, Zoltán Griger, et al.
Annals of the Rheumatic Diseases|June 20, 2025
The TFIID complex is a new autoantibody target in systemic sclerosisJean-Baptiste Vulsteke, Birthe Michiels, Vanessa Smith, et al.
Rheumatology (Oxford, England)|February 18, 2021
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathiesAlexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Rheumatology (Oxford, England)|October 24, 2021
Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathiesAlexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Ebiomedicine|September 28, 2023
Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathiesValérie Leclair, Angeles S Galindo-Feria, Simon Rothwell, et al.
Autoimmunity Reviews|March 13, 2026
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature reviewValentin Pillot, Segolene Toquet, Jean Luc Charuel, et al.
Seminars in Arthritis and Rheumatism|November 2, 2025
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysisTakahisa Gono, Albert Gil-Vila, Albert Selva-O'Callaghan, et al.
Pageof 3